Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRecord Regulatory News (REC)

Share Price Information for Record (REC)

Share Price is delayed by 15 minutes
Get Live Data
54.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (1.852%)
Market Cap: £104.31m
REC Live PriceLast checked at - London Stock Exchange

Intraday Record Share Chart

Directorate Change

16 Sep 2021 17:23

RNS Number : 0677M
Record PLC
16 September 2021
 

16 September 2021

 

Record plc

 

Board Change

Krystyna Nowak appointed as an independent non-executive director

Record plc ("Record"), the specialist currency and derivatives manager, today announces the appointment of Krystyna Nowak as an independent non-executive director. The appointment is effective from today.

Krystyna is currently a partner at Ridgeway, having previously been Managing Director of Norman Broadbent. Krystyna is also the Senior Independent Director at Aberdeen Asian Income Fund Ltd (AAIF). Prior to this, Krystyna worked at Citigroup in a variety of senior roles across shipping finance, oil project finance and risk management, in Europe and Asia.

Neil Record, Chairman of Record, commented: "I am very pleased indeed that Krystyna has accepted a position on the Record plc Board. Krystyna has a wealth of City experience, both in banking and in executive search. Her expertise in succession planning will be a particular bonus in this period of transition for Record. I warmly welcome her to the Board."

There are no other disclosures required under Listing Rule 9.6.13.

-Ends -

 

For further information, please contact:

 

Record plc Tel: +44 (0) 1753 852 222

Neil Record, Chairman

Leslie Hill, Chief Executive Officer

 

Buchanan Tel: +44 (0) 20 7466 5000

Giles Stewart record@buchanan.uk.com

Victoria Hayns

Henry Wilson

George Beale

Notes to Editors

 

Record plc

 

Founded in 1983, Record is an independent, market-leading specialist currency and derivatives manager with over 38 years of experience which has allowed us to develop a deep and fundamental understanding of the risk and reward opportunities within those markets.

 

Our range of products typically assist our clients in achieving either their risk-reduction (via Currency Hedging) or return-seeking (via Currency for Return) objectives.

 

Our clients are largely institutions, including pension funds, charities, foundations, endowments, and family offices, as well as other asset managers and corporates.

 

Record (LSE: REC) was admitted to trading on the London Stock Exchange on 3 December 2007.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUGPBUPGGQQ
Date   Source Headline
1st Jun 20263:56 pmRNSDirector/PDMR Shareholding
28th Apr 20264:49 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSRECORD PLC FOURTH QUARTER TRADING UPDATE (Q4 FY26)
15th Apr 202610:38 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNS-RSwiss pension fund partnership invests in NorthC
10th Mar 20262:00 pmRNSDirectorate change
4th Mar 20265:31 pmRNSDirector/PDMR Shareholding
28th Jan 20264:46 pmRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSThird Quarter Trading Update
31st Dec 202511:57 amRNSDirector/PDMR Shareholding
24th Dec 20259:23 amRNSDirector/PDMR Shareholding
24th Dec 20259:23 amRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSDirectorate change
2nd Dec 20255:26 pmRNSDirector/PDMR Shareholding
20th Nov 20258:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSHalf-year Financial Report
6th Nov 202511:32 amRNS-RInvestor Presentation via Investor Meet Company
29th Oct 202512:58 pmRNSDirector/PDMR Shareholding
24th Oct 20257:00 amRNSSecond Quarter Trading Update
14th Oct 202512:11 pmRNSDirectorate Change & Senior Subsidiary Appointment
10th Oct 20257:00 amRNSHolding(s) in Company
1st Oct 20253:40 pmRNSDirector/PDMR Shareholding
2nd Sep 20255:12 pmRNSDirector/PDMR Shareholding
11th Aug 20251:55 pmRNSDirector/PDMR Shareholding
31st Jul 20251:22 pmRNSDirector/PDMR Shareholding
31st Jul 20251:13 pmRNSDirector/PDMR Shareholding
25th Jul 20257:00 amRNSFirst Quarter Trading Update
24th Jul 20257:00 amRNSResult of AGM
4th Jul 202511:20 amRNSDirector/PDMR Shareholding
1st Jul 20254:29 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNS-RPublication of Sustainability & Climate Reports
25th Jun 202511:25 amRNSDirector/PDMR Shareholding
25th Jun 202511:23 amRNSDirector/PDMR Shareholding
24th Jun 20253:11 pmRNSNotice of AGM and Dividend Timetable
20th Jun 20259:00 amRNS-RInvestor presentation via Investor Meet Company
20th Jun 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNS-RNon-Binding Term Sheets for US$2.2 billion signed
29th May 202510:58 amRNSDirector/PDMR Shareholding
28th May 202512:21 pmRNSHolding(s) in Company
1st May 20252:21 pmRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSFourth Quarter Trading Update
31st Mar 20252:21 pmRNSDirector/PDMR Shareholding
18th Mar 20259:20 amRNS-RAPPOINTMENT OF ANDREAS DÄNZER AS GROUP CIO
28th Feb 20253:31 pmRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSThird Quarter Trading Update
31st Dec 20247:00 amRNSDirector/PDMR Shareholding
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
19th Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.